142 related articles for article (PubMed ID: 19957538)
1. Determination of antifungal activity of polyenzyme preparation Candidaseb using in vitro methods.
Joshi A; Deshpande S; Dohe V; Risbud S; Bharadwaj R
Hindustan Antibiot Bull; 2007 Feb-2008 Nov; 49-50(1-4):10-3. PubMed ID: 19957538
[TBL] [Abstract][Full Text] [Related]
2. In vitro synergic antifungal effect of MUC7 12-mer with histatin-5 12-mer or miconazole.
Wei GX; Bobek LA
J Antimicrob Chemother; 2004 May; 53(5):750-8. PubMed ID: 15073161
[TBL] [Abstract][Full Text] [Related]
3. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
Odds FC
Antimicrob Agents Chemother; 1982 Nov; 22(5):763-70. PubMed ID: 6295266
[TBL] [Abstract][Full Text] [Related]
4. Synergistic anticandidal activity of xanthorrhizol in combination with ketoconazole or amphotericin B.
Rukayadi Y; Lee K; Lee MS; Yong D; Hwang JK
FEMS Yeast Res; 2009 Dec; 9(8):1302-11. PubMed ID: 19663917
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility of Cryptococcus neoformans isolates from patients with acquired immunodeficiency syndrome.
Poon M; Cronin DC; Wormser GP; Bottone EJ
Arch Pathol Lab Med; 1988 Feb; 112(2):161-2. PubMed ID: 3276290
[TBL] [Abstract][Full Text] [Related]
6. The influence of antifungal drugs on adherence of Candida albicans to buccal epithelial cells.
Brenciaglia MI; Ghezzi MC; Cipriani P; Mancini C; Trancassini M
Chemioterapia; 1986 Jun; 5(3):200-3. PubMed ID: 3521918
[TBL] [Abstract][Full Text] [Related]
7. [Comparative study of two systems for the determination of the sensitivity of yeasts to antifungal agents].
de Montclos M; de Montclos H; Flandrois JP
Pathol Biol (Paris); 1992 May; 40(5):495-9. PubMed ID: 1495833
[TBL] [Abstract][Full Text] [Related]
8. [Determination of the in vitro antifungal susceptibility of clinically important yeasts using the Sensititre system].
Carrillo-Muñoz AJ; Quindós G; Gasser I; Tur-Tur C; Ruesga MT; Alonso-Vargas R; Arévalo P; Bornay-Llinares FJ; Santos P; del Valle O
Rev Esp Quimioter; 1999 Jun; 12(2):126-35. PubMed ID: 10562673
[TBL] [Abstract][Full Text] [Related]
9. Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans.
Gudewicz TM; Mader JT; Davis CP
Aviat Space Environ Med; 1987 Jul; 58(7):673-8. PubMed ID: 3304267
[TBL] [Abstract][Full Text] [Related]
10. Anti-Candida effects of estragole in combination with ketoconazole or amphotericin B.
Shin S; Pyun MS
Phytother Res; 2004 Oct; 18(10):827-30. PubMed ID: 15551395
[TBL] [Abstract][Full Text] [Related]
11. In vitro antifungal activity of sertaconazole.
Drouhet E; Dupont B
Arzneimittelforschung; 1992 May; 42(5A):705-10. PubMed ID: 1627187
[TBL] [Abstract][Full Text] [Related]
12. In vitro synergism between nyasol, an active compound isolated from Anemarrhena asphodeloides, and azole agents against Candida albicans.
Iida Y; Oh KB; Saito M; Matsuoka H; Kurata H
Planta Med; 2000 Jun; 66(5):435-8. PubMed ID: 10909263
[TBL] [Abstract][Full Text] [Related]
13. Lipid-covered drug particles: combined action of dioctadecyldimethylammonium bromide and amphotericin B or miconazole.
Lincopan N; Carmona-Ribeiro AM
J Antimicrob Chemother; 2006 Jul; 58(1):66-75. PubMed ID: 16636081
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
Tay ST; Tanty Haryanty T; Ng KP; Rohani MY; Hamimah H
Mycoses; 2006 Jul; 49(4):324-30. PubMed ID: 16784448
[TBL] [Abstract][Full Text] [Related]
15. Antifungal drug combinations for Cryptococcus neoformans and Prototheca spp.
Srimuang S; Prariyachatigul C; Chaiprasert A; Rungsipanuratn W; Tanphaichitra D
J Med Assoc Thai; 2000 Jan; 83(1):57-60. PubMed ID: 10710870
[TBL] [Abstract][Full Text] [Related]
16. [Identification and susceptibility of clinically isolated yeast-like fungi].
Fukuchi K; Tanaka Y; Oguro T; Wakuta R; Sugita M; Takagi Y; Gomi K
Rinsho Byori; 1990 Aug; 38(8):931-6. PubMed ID: 2232256
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of three topical antimycotics against ring-worm fungi singly and in combination.
Rai MK; Upadhyay SK; Agrawal SC
Hindustan Antibiot Bull; 1992; 34(3-4):104-7. PubMed ID: 1289296
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: a modified XTT tetrazolium assay using synchronised C. albicans cells.
Hawser S
J Med Vet Mycol; 1996; 34(2):149-52. PubMed ID: 8732362
[TBL] [Abstract][Full Text] [Related]
19. Antifungal activity of flocculosin, a novel glycolipid isolated from Pseudozyma flocculosa.
Mimee B; Labbé C; Pelletier R; Bélanger RR
Antimicrob Agents Chemother; 2005 Apr; 49(4):1597-9. PubMed ID: 15793149
[TBL] [Abstract][Full Text] [Related]
20. [The effect of propyl gallate on the activity of various antifungal drugs against filamentous fungi in vitro].
Xu Y; Pang GR; Lü XF; Chen ZJ; Sun ST; Song JZ
Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):309-12. PubMed ID: 16762206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
